"The AACU has been discussing the evolution of state policy to ensure that biomarker testing, including PSA screening, is covered by payers," writes Ron Lanton, Esq.
Ron Lanton, Esq
Advertisement
Lanton is government affairs director for the American Association of Clinical Urology.
Articles by Ron Lanton, Esq
Advertisement
Latest Updated Articles
Advertisement
Advertisement
